Success Story: Advancing Early Diagnosis and Targeted Therapeutics for Infectious Diseases: NIW Approval Secured for a Biomedical Science Researcher
Client’s Testimonial:
“Very professional service, response to inquires within 48 hours all the time, my I-140 NIW was approved under regular processing 25 months after filing it, with no RFE. Thank you!”
On September 16th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Student in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: PhD Student
Country of Origin: Bolivia
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: September 16th, 2026
Processing Time: 25 months, 8 days
Case Summary:
A strong record of independent research influence provided the foundation for this EB-2 National Interest Waiver (NIW) case. North America Immigration Law Group represented a biomedical science researcher holding a Master of Science in epidemiological research whose work focuses on developing early diagnosis and treatment approaches to protect patient populations from infectious diseases.
An Established Record Before the Proposed Endeavor
Long before filing the petition, the client's scientific contributions had attracted meaningful reliance from independent researchers across the global medical community. The record documented 10 peer-reviewed journal articles (including 3 first-authored papers), accumulating 45 citations from independent scholars. Rather than presenting these raw metrics as self-evidently sufficient, our legal team analyzed how an adjudicator evaluates scientific value, demonstrating that his research appeared in top-tier specialized periodicals.
Furthermore, his scientific authority was recognized through his service as an editorial committee reviewer for a peer-reviewed health sciences journal, as well as major grant funding supported by the U.S. Cystic Fibrosis Foundation.
A Broader Infectious Disease Endeavor With Practical Applications
Against this background of established expertise, we presented the client's proposed endeavor as a natural continuation of his research successes. Currently conducting biomedical research at a U.S. academic institution, the client proposed to continue developing early diagnosis and treatment approaches to enable treatment of infectious microbe-driven diseases in order to protect vulnerable patient populations.
From Research Influence to NIW Approval
The petition was further corroborated by 4 recommendation letters from field experts who verified the technical necessity and national importance of his research:
"With a reputation for excellence, [Client] consistently produces insights that shape the field’s understanding and drive advancements in healthcare practices."
By connecting his scholarly output, independent citation reliance, editorial reviewer service, grant backing, and practical public health applications into a cohesive narrative, our firm successfully secured his I-140 NIW approval. We congratulate the client and look forward to his continued contributions to infectious disease diagnostics and global health equity.